Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study

American Journal of Gastroenterology

Volumn 115, Issue 5, 2020, Pages 766-773

  Pan, Lei ^a,b   Mu, Mi ^b   Yang, Pengcheng ^c   Sun, Yu ^d   Wang, Runsheng ^b   Yan, Junhong ^a   Li, Pibao ^e   Hu, Baoguang ^a   Wang, Jing ^a   Hu, Chao ^b   Jin, Yuan ^d   Niu, Xun ^d   Ping, Rongyu ^b   Du, Yingzhen ^b   Li, Tianzhi ^b   Xu, Guogang ^b   Hu, Qinyong ^c   Tu, Lei ^d  

^a BINZHOU MEDICAL UNIVERSITY HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e Department of Urology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; LIVER ENZYME;

ABDOMINAL PAIN; ADULT; ARTICLE; CHINA; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIARRHEA; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE COUNT; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; VOMITING;

EID: 85085079703     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.14309/ajg.0000000000000620     Document Type: Article

References (22)

1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: Challenges for global health governance. JAMA2020;323: 709-10.
2. Wu Y, Ho W, Huang Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 2020;395:949-50.
3. Legido-Quigley H, Asgari N, Teo YY, et al. Are high-performing health systems resilient against the COVID-19 epidemic? Lancet 2020;395: 848-50.
4. Wang P, Anderson N, Pan Y, et al. The SARS-CoV-2 outbreak: Diagnosis, infection prevention, and public perception. Clin Chem 2020. [Epub ahead of print March 10, 2020].
5. Khot WY, Nadkar MY. The 2019 novel coronavirus outbreak-A global threat. J Assoc Physicians India 2020;68:67-71.
6. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069.
7. Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls: Treasure Island, 2020. [Epub ahead of print March 20, 2020].
8. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020. [Epub ahead of print March 03, 2020].
9. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13.
10. Gao QY, Chen YX, Fang JY. 2019 novel coronavirus infection and gastrointestinal tract. J Dig Dis 2020. [Epub ahead of print February 25, 2020].
11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
12. Yao N, Wang SN, Lian JQ, et al. Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020;28:E003.
13. Hu LL, Wang WJ, Zhu QJ, et al. Novel coronavirus pneumonia related liver injury: Etiological analysis and treatment strategy [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020;28:E001.
14. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A singlecentered, retrospective, observational study. Lancet Respir Med 2020. [Epub ahead of print February 24, 2020].
15. Guan GW, Gao L, Wang JW, et al. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020;28:E002.
16. Tang A, Tong ZD, Wang HL, et al. Detection of novel coronavirus by RTPCR in stool specimen from asymptomatic child, China. Emerg Infect Dis 2020;26. [Epub ahead of print March 09, 2020].
17. Xie C, Jiang L, Huang G, et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis 2020;93:264-7.
18. Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020. [Epub ahead of print March 03, 2020].
19. Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008;105:2117-22.
20. Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 2017;15:55-63.
21. He Y, Wen Q, Yao F, et al. Gut-lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol 2017;43:81-95.
22. Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: A multicenter descriptive study. Clin Infect Dis 2020. [Epub ahead of print February 29, 2020].